Page last updated: 2024-08-22

platinum and sc002

platinum has been researched along with sc002 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Appenzeller, C; Bar, J; Cho, BC; Colinet, B; Gottfried, M; Gutierrez, V; Helland, A; Hung, JY; Johnson, ML; Komarnitsky, P; Laktionov, K; Lena, H; Luo, Y; Maag, D; Nickner, C; Okamoto, I; Rich, P; Sun, Z; Vajikova, A; van der Leest, C; Wolf, M; Zvirbule, Z1

Trials

1 trial(s) available for platinum and sc002

ArticleYear
Rovalpituzumab Tesirine as a Maintenance Therapy After First-Line Platinum-Based Chemotherapy in Patients With Extensive-Stage-SCLC: Results From the Phase 3 MERU Study.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2021, Volume: 16, Issue:9

    Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Benzodiazepinones; Double-Blind Method; Humans; Immunoconjugates; Lung Neoplasms; Middle Aged; Platinum

2021